Literature DB >> 2311631

Secondary amyloidosis in glycogen storage disease type Ib.

M Kikuchi1, K Haginoya, S Miyabayashi, Y Igarashi, K Narisawa, K Tada.   

Abstract

We observed the development of generalized amyloidosis in a girl with glycogen storage disease type Ib (GSD-Ib) who showed neutropenia, neutrophil dysfunction and recurrent infections. Renal and thyroid biopsies showed secondary amyloidosis, characterized by the presence of potassium permanganate sensitive Dylon positive deposits in glomeruli, renal vessels and thyroid interstitium. Immunohistochemistry showed that the deposits were composed of amyloid A (AA) protein. Possibly neutrophil abnormalities are involved in the pathogenesis of amyloidosis.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2311631     DOI： 10.1007/bf02171563

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  13 in total

1.  A new variant of glycogen storage disease type I probably due to a defect in the glucose-6-phosphate transport system.

Authors:  K Narisawa; Y Igarashi; H Otomo; K Tada
Journal:  Biochem Biophys Res Commun       Date:  1978-08-29       Impact factor: 3.575

2.  Amyloid fibril proteins: proof of homology with immunoglobulin light chains by sequence analyses.

Authors:  G G Glenner; W Terry; M Harada; C Isersky; D Page
Journal:  Science       Date:  1971-06-11       Impact factor: 47.728

3.  Type Ib glycogen storage disease is caused by a defect in the glucose-6-phosphate translocase of the microsomal glucose-6-phosphatase system.

Authors:  A J Lange; W J Arion; A L Beaudet
Journal:  J Biol Chem       Date:  1980-09-25       Impact factor: 5.157

4.  Secondary amyloidosis in Crohn's disease of childhood.

Authors:  B S Kirschner; W S Samowitz
Journal:  J Pediatr Gastroenterol Nutr       Date:  1986 Sep-Oct       Impact factor: 2.839

5.  Impaired metabolic function of polymorphonuclear leukocytes in glycogen storage disease Ib.

Authors:  M Gahr; K Heyne
Journal:  Eur J Pediatr       Date:  1983-09       Impact factor: 3.183

6.  The amino acid sequence of a major nonimmunoglobulin component of some amyloid fibrils.

Authors:  M Levin; E C Franklin; B Frangione; M Pras
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

7.  Neutropenia and impaired neutrophil migration in type IB glycogen storage disease.

Authors:  A L Beaudet; D C Anderson; V V Michels; W J Arion; A J Lange
Journal:  J Pediatr       Date:  1980-12       Impact factor: 4.406

8.  Potassium permanganate reaction in amyloidosis. A histologic method to assist in differentiating forms of this disease.

Authors:  J R Wright; E Calkins; R L Humphrey
Journal:  Lab Invest       Date:  1977-03       Impact factor: 5.662

9.  DMSO and colchicine therapy in amyloid disease.

Authors:  M A Scheinberg; J C Pernambuco; M D Benson
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

10.  Inflammatory bowel disease in glycogen storage disease type Ib.

Authors:  T F Roe; D W Thomas; V Gilsanz; H Isaacs; J B Atkinson
Journal:  J Pediatr       Date:  1986-07       Impact factor: 4.406
View more
  2 in total

Review 1.  Type I glycogen storage disease: kidney involvement, pathogenesis and its treatment.

Authors:  Y T Chen
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

2.  AA Amyloidosis in a patient with glycogen storage disorder and progressive chronic kidney disease.

Authors:  Jonathan Dick; Nicola Kumar; Catherine Horsfield; Satish Jayawardene
Journal:  Clin Kidney J       Date:  2012-11-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.